These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33578442)

  • 1. Lumbar Puncture Opening Pressure in Patients with Spinal Muscular Atrophy.
    Becker LL; Weiß C; Tietze A; Martiny V; Kaindl AM
    Neuropediatrics; 2021 Jun; 52(3):219-223. PubMed ID: 33578442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen.
    Machetanz G; Grziwotz M; Semmler L; Maier M; Maegerlein C; Deschauer M
    J Neuromuscul Dis; 2023; 10(4):719-725. PubMed ID: 37248913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
    Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
    Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
    Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
    J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
    Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
    J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral interlaminar fenestration on the convex side provides a reliable access for intrathecal administration of nusinersen in spinal muscular atrophy: a retrospective study.
    Wang Z; Feng E; Jiao Y; Zhao J; Chen X; Zhang H; Liang J; Li Z; Cui X; Chen W; Shen J
    Orphanet J Rare Dis; 2023 Nov; 18(1):369. PubMed ID: 38031122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A horizontal and perpendicular interlaminar approach for intrathecal nusinersen injection in patients with spinal muscular atrophy and scoliosis: an observational study.
    Huang C; Zhang Y; Diedrich DA; Li J; Luo W; Zhao X; Guo Y; Luo Y; Zhang T; Wang X; Huang W; Xiao Y
    Orphanet J Rare Dis; 2024 Jul; 19(1):268. PubMed ID: 39010073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography-guided transforaminal lumbar puncture using local anesthesia and a straight 22-gauge spinal needle for intrathecal nusinersen in adults: Findings in 77 procedures.
    Cox M; Atsina KB; Ramchand P; Ji J; Sedora-Roman N; Pukenas B
    Interv Neuroradiol; 2022 Jun; 28(3):262-265. PubMed ID: 34424100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis.
    Rosiak G; Lusakowska A; Milczarek K; Konecki D; Fraczek A; Rowinski O; Kostera-Pruszczyk A
    Neuroradiology; 2021 Apr; 63(4):539-545. PubMed ID: 33512541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience.
    Haché M; Swoboda KJ; Sethna N; Farrow-Gillespie A; Khandji A; Xia S; Bishop KM
    J Child Neurol; 2016 Jun; 31(7):899-906. PubMed ID: 26823478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needleless inhaled anesthesia with sevoflurane: Advantages of a simplified approach for children with spinal muscular atrophy undergoing intrathecal administration of nusinersen.
    Salerno A; Picconi E; Genovese O; Piastra M; Pulitanò SM; Tosi F; Mancino A; Pane M; De Sanctis R; Carlini D; Mercuri EM; Conti G
    Paediatr Anaesth; 2023 Apr; 33(4):282-290. PubMed ID: 36636888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients.
    Veiga-Canuto D; Cifrián-Pérez M; Pitarch-Castellano I; Vázquez-Costa JF; Aparici F
    Eur J Neurol; 2021 Feb; 28(2):676-680. PubMed ID: 33051940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.
    Mousa MA; Aria DJ; Schaefer CM; Kaye RD; Abruzzo TA; Bernes SM; Willard SD; Riemann MC; Towbin RB
    Pediatr Radiol; 2018 Nov; 48(12):1797-1805. PubMed ID: 30022258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: A retrospective cohort study.
    Shimizu-Motohashi Y; Chiba E; Mizuno K; Yajima H; Ishiyama A; Takeshita E; Sato N; Oba M; Sasaki M; Ito S; Komaki H
    Brain Dev; 2023 Mar; 45(3):161-170. PubMed ID: 36460551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound assisted lumbar intrathecal administration of nusinersen in adult patients with spinal muscular atrophy: A case series.
    Zanfini BA; Catarci S; Patanella AK; Pane M; Frassanito L; Filipponi E; Mercuri E; Sabatelli M; Draisci G
    Muscle Nerve; 2021 Nov; 64(5):594-599. PubMed ID: 34396547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nusinersen: A Review in 5q Spinal Muscular Atrophy.
    Hoy SM
    CNS Drugs; 2021 Dec; 35(12):1317-1328. PubMed ID: 34850360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nusinersen treatment of spinal muscular atrophy - a systematic review.
    Albrechtsen SS; Born AP; Boesen MS
    Dan Med J; 2020 Aug; 67(9):. PubMed ID: 32800069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials.
    Darras BT; Farrar MA; Mercuri E; Finkel RS; Foster R; Hughes SG; Bhan I; Farwell W; Gheuens S
    CNS Drugs; 2019 Sep; 33(9):919-932. PubMed ID: 31420846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis.
    Flotats-Bastardas M; Linsler S; Zemlin M; Meyer S
    Pediatr Neurosurg; 2020; 55(1):54-57. PubMed ID: 31722365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.